After stroke, NGN1 and NGN2 protein levels were significantly increased in the two neurogenic regions, but not the peri-infarct cortex, of the TMF-treated WT mice and AHRcKO mice compared with the AHRflx/flx controls (Fig. 5b–d). The gene discussed is NEUROG1; the disease is Stroke.